Name (Synonyms) | Correlation | |
---|---|---|
drug2872 | Test: Favipiravir 200 mg (LOQULAR) Wiki | 1.00 |
drug654 | Chloroquine Wiki | 0.35 |
drug1869 | Nitazoxanide Wiki | 0.32 |
drug1489 | Ivermectin Wiki | 0.22 |
drug313 | Azithromycin Wiki | 0.17 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A single dose of Reference product containing 200 mg favipiravir and a single dose of Test product containing 200 mg favipiravir or vice versa; administered with 240 mL of water at room temperature, in each period under fasting conditions with current pandemic precautions.
Description: AUC0-tlast of favipiravir
Measure: Primary PK End Points AUC0-tlast Time: 12 weeksDescription: Cmax of favipiravir
Measure: Primary PK End Points Cmax Time: 13 weeksDescription: AUC0-inf of favipiravir
Measure: Secondary PK End Points AUC0-inf Time: 14 weeksDescription: tmax of favipiravir
Measure: Secondary PK End Points tmax Time: 15 weeks